BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18459126)

  • 1. Prostaglandin F2alpha involves heparan sulphate sugar chains and FGFRs to modulate osteoblast growth and differentiation.
    Sabbieti MG; Agas D; Materazzi S; Capacchietti M; Materazzi G; Hurley MM; Menghi G; Marchetti L
    J Cell Physiol; 2008 Oct; 217(1):48-59. PubMed ID: 18459126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-apoptotic Bcl-2 enhancing requires FGF-2/FGF receptor 1 binding in mouse osteoblasts.
    Agas D; Marchetti L; Menghi G; Materazzi S; Materazzi G; Capacchietti M; Hurley MM; Sabbieti MG
    J Cell Physiol; 2008 Jan; 214(1):145-52. PubMed ID: 17559077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGF2alpha increases FGF-2 and FGFR2 trafficking in Py1a rat osteoblasts via clathrin independent and importin beta dependent pathway.
    Marchetti L; Sabbieti MG; Agas D; Menghi M; Materazzi G; Menghi G; Hurley MM
    J Cell Biochem; 2006 Apr; 97(6):1379-92. PubMed ID: 16365892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins differently regulate FGF-2 and FGF receptor expression and induce nuclear translocation in osteoblasts via MAPK kinase.
    Sabbieti MG; Marchetti L; Gabrielli MG; Menghi M; Materazzi S; Menghi G; Raisz LG; Hurley MM
    Cell Tissue Res; 2005 Feb; 319(2):267-78. PubMed ID: 15654655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin F2α: a bone remodeling mediator.
    Agas D; Marchetti L; Hurley MM; Sabbieti MG
    J Cell Physiol; 2013 Jan; 228(1):25-9. PubMed ID: 22585670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
    Mundhenke C; Meyer K; Drew S; Friedl A
    Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E; Richardson TP; Nugent MA
    J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular specificity for the activation of fibroblast growth factor-2 by heparan sulfate proteoglycan.
    Fiore MM
    Biochem Biophys Res Commun; 2001 Jun; 284(2):384-8. PubMed ID: 11394890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2.
    Jackson RA; Murali S; van Wijnen AJ; Stein GS; Nurcombe V; Cool SM
    J Cell Physiol; 2007 Jan; 210(1):38-50. PubMed ID: 17051597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis.
    Jackson RA; Nurcombe V; Cool SM
    Gene; 2006 Sep; 379():79-91. PubMed ID: 16797878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2.
    Song SJ; Cool SM; Nurcombe V
    J Cell Biochem; 2007 Feb; 100(2):402-11. PubMed ID: 16924669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
    Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
    Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
    Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
    Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex.
    Leadbeater WE; Gonzalez AM; Logaras N; Berry M; Turnbull JE; Logan A
    J Neurochem; 2006 Feb; 96(4):1189-200. PubMed ID: 16417571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding.
    Gopalakrishnan M; Forsten-Williams K; Täuber UC
    J Theor Biol; 2004 Mar; 227(2):239-51. PubMed ID: 14990388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
    Tumova S; Hatch BA; Law DJ; Bame KJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.